NF-kB in development and progression of human cancer

X Dolcet, D Llobet, J Pallares, X Matias-Guiu - Virchows archiv, 2005 - Springer
The nuclear factor kB (NF-kB) comprises a family of transcription factors involved in the
regulation of a wide variety of biological responses. NF-kB plays a well-known function in …

Molecular pathology of endometrial hyperplasia and carcinoma

X Matias-Guiu, L Catasus, E Bussaglia, H Lagarda… - Human pathology, 2001 - Elsevier
Four different genetic abnormalities may occur in endometrioid adenocarcinomas of the
endometrium (mircosatellite instability and mutations in the PTEN, k-RAS and β-catenin …

[HTML][HTML] Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of …

RA Soslow, C Tornos, KJ Park, A Malpica… - International journal …, 2019 - journals.lww.com
In this review, we sought to address 2 important issues in the diagnosis of endometrial
carcinoma: how to grade endometrial endometrioid carcinomas and how to incorporate the …

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

N Concin, X Matias-Guiu, I Vergote, D Cibula… - International Journal of …, 2021 - ijgc.bmj.com
A European consensus conference on endometrial carcinoma was held in 2014 to produce
multi-disciplinary evidence-based guidelines on selected questions. Given the large body of …

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

M Esteller, JM Silva, G Dominguez… - JNCI: Journal of the …, 2000 - academic.oup.com
Background: Inherited mutations in the BRCA1 gene may be responsible for almost half of
inherited breast carcinomas. However, somatic (acquired) mutations in BRCA1 have not …

Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer

M Scaltriti, F Rojo, A Ocaña, J Anido… - Journal of the …, 2007 - academic.oup.com
Background Women with HER2–overexpressing breast cancers have poor prognosis, and
many are resistant to the HER2 monoclonal antibody trastuzumab. A subgroup of HER2 …

FIGO staging of endometrial cancer: 2023

JS Berek, X Matias‐Guiu, C Creutzberg… - … of Gynecology & …, 2023 - Wiley Online Library
Introduction Many advances in the understanding of the pathologic and molecular features
of endometrial cancer have occurred since the FIGO staging was last updated in 2009 …

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

S Moran, A Martínez-Cardús, S Sayols… - The Lancet …, 2016 - thelancet.com
Background Cancer of unknown primary ranks in the top ten cancer presentations and has
an extremely poor prognosis. Identification of the primary tumour and development of a …

[HTML][HTML] hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

M Esteller, L Catasus, X Matias-Guiu, GL Mutter… - The American journal of …, 1999 - Elsevier
It has recently been suggested that silencing of the hMLH1 gene by promoter
hypermethylation is the mechanism underlying the presence of the microsatellite instability …

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

V Trovisco, I Vieira de Castro, P Soares… - The Journal of …, 2004 - Wiley Online Library
Mutations in the BRAF gene have recently been detected in a wide range of neoplastic
lesions with a particularly high prevalence in melanoma and papillary thyroid carcinoma …